Last reviewed 2026-05-22 · How we verify

SULFAGUANIDINE

FDA-approved withdrawn Small molecule ✓ Verified May 2026 Quality 0/100

SULFAGUANIDINE is a drug. It is currently FDA-approved.

Sulfaguanidine is a small molecule with the synonyms GPPE SUSP FTE, Guanimycin, NSC-14041, Sulfaguanidina, and Sulfaguanidine.

At a glance

Generic name	SULFAGUANIDINE
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SULFAGUANIDINE CI brief — competitive landscape report
SULFAGUANIDINE updates RSS · CI watch RSS

Frequently asked questions about SULFAGUANIDINE

What is SULFAGUANIDINE?

SULFAGUANIDINE is a Small molecule drug.

What development phase is SULFAGUANIDINE in?

SULFAGUANIDINE is FDA-approved (marketed).

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing